杜振新

All filings by 杜振新 on record concern 辰欣药业, in the capacity of chief executive. Between 27 April 2022 and 20 October 2022, the trades on record add up to 3 filings.

Purchases make up the whole of the open-market record (3 purchases, €2.1M). Unlike grants, an open-market purchase is paid for by the insider, at the market price.

A typical purchase (the median) is worth €732k. No cluster: in 3 purchases, no other insider of the company bought within 30 days.

The latest filing, published on 20 October 2022, reports an open-market purchase of €580k in 辰欣药业. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.